BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18394854)

  • 1. Phantom shocks in patients with an implantable cardioverter defibrillator.
    Juan EA; Pollack M
    J Emerg Med; 2010 Jan; 38(1):22-4. PubMed ID: 18394854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients.
    Starrenburg A; Kraaier K; Pedersen S; Scholten M; Van Der Palen J
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):768-73. PubMed ID: 24456312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
    Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
    Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and depression among the patients with frequent implantable cardioverter-defibrillator discharges.
    Maryniak A; Szumowski L; Orczykowski M; Przybylski A; Walczak F
    Int J Cardiol; 2009 Feb; 132(2):e80-1. PubMed ID: 18061290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter defibrillator storm: nursing care issues for patients and families.
    O'Brien MC; Langberg J; Valderrama AL; Kirkendoll K; Romeiko N; Dunbar SB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):9-16, ix. PubMed ID: 15749396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Magnetic attraction" in the pediatric emergency department: the case of a malfunctioning implantable cardioverter-defibrillator.
    Ladouceur VB; Khairy P; Béland MJ; Bhanji F
    Pediatr Emerg Care; 2012 Jun; 28(6):562-5. PubMed ID: 22668661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICD and neuromodulation devices: is peaceful coexistence possible?
    Molon G; Perrone C; Maines M; Costa A; Comisso J; Boi A; Moro E; Vergara G; Barbieri E
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):690-3. PubMed ID: 21303391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy.
    Vollmann D; Lüthje L; Zabel M
    Europace; 2007 May; 9(5):275-7. PubMed ID: 17369268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
    Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
    Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with 'appropriate' interrogation.
    Farwell D; Redpath C; Birnie D; Gollob M; Lemery R; Posan E; Green M
    Europace; 2008 Jun; 10(6):726-8. PubMed ID: 18456645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.